Nexium: Nexium for injection and infusion is indicated for: Gastric antisecretory treatment when the oral route is not possible, such as: gastroesophageal reflux disease in patients with esophagitis and/or severe symptoms of reflux.
Healing of gastric ulcers associate with NSAID therapy.
Prevention of gastric and duodenal ulcers associated with NSAID therapy, in patients at risk.
Prevention of rebleeding following therapeutic endoscopy for acute bleeding gastric or duodenal ulcers.
Nexium MUPS: Nexium MUPS tablets are indicated for: Gastroesophageal Reflux Disease (GERD): treatment of erosive reflux esophagitis; long-term management of patients with healed esophagitis to prevent relapse - symptomatic treatment of gastroesophageal reflux disease (GERD).
In combination with an appropriate antibacterial therapeutic regimen for the eradication of Helicobacter pylori: healing of Helicobacter pylori associated duodenal ulcer and; prevention of relapse of peptic ulcers in patients with Helicobacter pylori associated ulcers.
Patients requiring continued NSAID therapy: healing of gastric ulcers associated with NSAID therapy; prevention of gastric and duodenal ulcers associated with NSAID therapy in patients at risk.
Prolonged treatment after i.v. induced prevention of rebleeding of peptic ulcers.
Treatment of Zollinger Ellison Syndrome.